Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation

NCT05501756 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Allogeneic Hematopoietic Cell Transplantation

Interventions

DRUG: Alemtuzumab

Sponsor

Children's Hospital Medical Center, Cincinnati